Pnc Financial Services Group, Inc. Genmab A/S Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 93,278 shares of GMAB stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,278

Previous 98,052 4.87%

Holding current value

$1.92 Million

Previous $2.46 Million 7.71%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$23.84 - $28.48 $113,812 - $135,963	-4,774 Reduced 4.87%	93,278 $2.27 Million
Q2 2024 Aug 09, 2024	SELL	$25.13 - $30.27 $234,161 - $282,055	-9,318 Reduced 8.68%	98,052 $2.46 Million
Q1 2024 May 10, 2024	SELL	$26.43 - $32.77 $1.53 Million - $1.89 Million	-57,817 Reduced 35.0%	107,370 $3.21 Million
Q4 2023 Feb 09, 2024	BUY	$27.94 - $35.44 $236,456 - $299,928	8,463 Added 5.4%	165,187 $5.26 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $127,359 - $152,528	3,611 Added 2.36%	156,724 $5.53 Million
Q2 2023 Aug 11, 2023	BUY	$37.4 - $42.94 $220,585 - $253,260	5,898 Added 4.01%	153,113 $5.82 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $239,311 - $296,532	-6,861 Reduced 4.45%	147,215 $5.56 Million
Q4 2022 Feb 10, 2023	SELL	$33.8 - $47.06 $1.11 Million - $1.55 Million	-32,834 Reduced 17.57%	154,076 $6.53 Million
Q3 2022 Nov 10, 2022	SELL	$31.52 - $373.61 $587,501 - $6.96 Million	-18,639 Reduced 9.07%	186,910 $6.01 Million
Q2 2022 Aug 12, 2022	BUY	$26.83 - $38.57 $21,678 - $31,164	808 Added 0.39%	205,549 $6.68 Million
Q1 2022 May 12, 2022	SELL	$30.95 - $39.68 $1.48 Million - $1.89 Million	-47,678 Reduced 18.89%	204,741 $7.41 Million
Q4 2021 Feb 11, 2022	SELL	$35.87 - $47.12 $221,568 - $291,060	-6,177 Reduced 2.39%	252,419 $9.99 Million
Q3 2021 Nov 05, 2021	SELL	$41.55 - $48.72 $78,820 - $92,421	-1,897 Reduced 0.73%	258,596 $11.3 Million
Q2 2021 Aug 06, 2021	BUY	$32.88 - $44.57 $2.76 Million - $3.74 Million	83,895 Added 47.51%	260,493 $10.6 Million
Q1 2021 May 07, 2021	SELL	$30.92 - $44.4 $2.32 Million - $3.33 Million	-75,079 Reduced 29.83%	176,598 $5.8 Million
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $310,951 - $376,540	9,238 Added 3.81%	251,677 $10.2 Million
Q3 2020 Nov 06, 2020	BUY	$33.07 - $38.68 $2.94 Million - $3.44 Million	88,878 Added 57.88%	242,439 $8.88 Million
Q2 2020 Aug 07, 2020	BUY	$20.05 - $33.89 $2.85 Million - $4.82 Million	142,364 Added 1271.45%	153,561 $5.2 Million
Q1 2020 May 08, 2020	BUY	$17.15 - $25.22 $4,544 - $6,683	265 Added 2.42%	11,197 $237,000
Q4 2019 Feb 07, 2020	BUY	$18.88 - $24.14 $15,292 - $19,553	810 Added 8.0%	10,932 $244,000
Q3 2019 Nov 08, 2019	BUY	$18.0 - $21.38 $182,196 - $216,408	10,122 New	10,122 $205,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Genmab A/S Transaction History